Breaking News

Recipharm Launches Inhalation Offering

Offers fully integrated service from early stage development through to commercial manufacturing for MDIs, DPIs, and nasal sprays

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Recipharm has launched its inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing. Recipharm Inhalation Solutions offers pharmaceutical companies an outsourcing service for inhalation products, including metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nasal sprays. The offering follows the acquisition of Sanofi’s inhalation manufacturing business in Holmes Chapel, UK in June 2018, which speciali...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters